Asset Classes

Emerging Markets Rally Riding on Earnings Growth
Pharma’s Top Innovators Positioned for Success
Seeing Through the Bond-Bubble Hype
Munis: Why We’re Bullish on Hospitals, Despite Uncertainty
Highlights From Our Midyear Outlook
From Melon Trucks to Ferraris: Charting China’s Meteoric Change
India Leading an Emerging Markets Rebound
Pharma’s Next Big Innovation May Be Affordability
Political Speed Bumps on China’s Road to Reform
Chilly Climate for Multinationals? What Investors Should Know
View Disclosure